Differential activation of the Toll-like receptor 2/6 complex by lipoproteins of Streptococcus suis serotypes 2 and 9

Veterinary Microbiology

Volumn 143, Issue 2-4, 2010, Pages 363-370

  Wichgers Schreur, Paul J ^a,b   Rebel, Johanna M J ^a   Smits, Mari A ^a   van Putten, Jos P M ^b   Smith, Hilde E ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Lipoproteins; Streptococcus suis; TLR activation

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPROTEIN; LIPOPROTEIN LIPASE; PENICILLIN G; PROTEIN KINASE C; PROTEIN MD 2; SODIUM HYDROXIDE; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6;

ARTICLE; BACTERIAL CELL WALL; CELL ACTIVATION; COMPLEX FORMATION; CONTROLLED STUDY; HELA CELL; HUMAN; INNATE IMMUNITY; MOLECULAR SIZE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN HYDROLYSIS; PROTEIN SECRETION; SEROTYPE; STRAIN DIFFERENCE; STREPTOCOCCUS SUIS;

CAPSID PROTEINS; CELL WALL; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; LIPOPROTEINS; PENICILLINS; STREPTOCOCCUS SUIS; TOLL-LIKE RECEPTOR 2;

STREPTOCOCCUS SUIS; SUIDAE;

EID: 77953120880     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2009.12.010     Document Type: Article

References (36)

1. Alexopoulou L., Thomas V., Schnare M., Lobet Y., Anguita J., Schoen R.T., Medzhitov R., Fikrig E., Flavell R.A. Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice. Nat. Med. 2002, 8:878-884.
2. Arends J.P., Zanen H.C. Meningitis caused by Streptococcus suis in humans. Rev. Infect. Dis. 1988, 10:131-137.
3. Beineke A., Bennecke K., Neis C., Schroder C., Waldmann K.H., Baumgartner W., Valentin-Weigand P., Baums C.G. Comparative evaluation of virulence and pathology of Streptococcus suis serotypes 2 and 9 in experimentally infected growers. Vet. Microbiol. 2008, 128:423-430.
4. Bungener W., Bialek R. Fatal Streptococcus suis septicemia in an abattoir worker. Eur. J. Clin. Microbiol. Infect. Dis. 1989, 8:306-308.
5. Chen C., Tang J., Dong W., Wang C., Feng Y., Wang J., Zheng F., Pan X., Liu D., Li M., Song Y., Zhu X., Sun H., Feng T., Guo Z., Ju A., Ge J., Dong Y., Sun W., Jiang Y., Wang J., Yan J., Yang H., Wang X., Gao G.F., Yang R., Wang J., Yu J. A glimpse of streptococcal toxic shock syndrome from comparative genomics of S. suis 2 Chinese isolates. PLoS One 2007, 2:e315.
6. Gottschalk M., Segura M., Xu J. Streptococcus suis infections in humans: the Chinese experience and the situation in North America. Anim. Health. Res. Rev. 2007, 8:29-45.
7. Graveline R., Segura M., Radzioch D., Gottschalk M. TLR2-dependent recognition of Streptococcus suis is modulated by the presence of capsular polysaccharide which modifies macrophage responsiveness. Int. Immunol. 2007, 19:375-389.
8. Hashimoto M., Tawaratsumida K., Kariya H., Aoyama K., Tamura T., Suda Y. Lipoprotein is a predominant Toll-like receptor 2 ligand in Staphylococcus aureus cell wall components. Int. Immunol. 2006, 18:355-362.
9. Holden M.T., Hauser H., Sanders M., Ngo T.H., Cherevach I., Cronin A., Goodhead I., Mungall K., Quail M.A., Price C., Rabbinowitsch E., Sharp S., Croucher N.J., Chieu T.B., Mai N.T., Diep T.S., Chinh N.T., Kehoe M., Leigh J.A., Ward P.N., Dowson C.G., Whatmore A.M., Chanter N., Iversen P., Gottschalk M., Slater J.D., Smith H.E., Spratt B.G., Xu J., Ye C., Bentley S., Barrell B.G., Schultsz C., Maskell D.J., Parkhill J. Rapid evolution of virulence and drug resistance in the emerging zoonotic pathogen Streptococcus suis. PLoS One 2009, 4:e6072.
10. Hussain M., Ichihara S., Mizushima S. Mechanism of signal peptide cleavage in the biosynthesis of the major lipoprotein of the Escherichia coli outer membrane. J. Biol. Chem. 1982, 257:5177-5182.
11. Keestra A.M., de Zoete M.R., van Aubel A.M.H., van Putten J.P.M. The central leucine-rich repeat region of chicken TLR16 dictates unique ligand specificity and species-specific interaction with TLR2. J. Immunol. 2007, 178:7110-7119.
12. Keestra A.M., van Putten J.P.M. Unique properties of the chicken TLR4/MD-2 complex: selective lipopolysaccharide activation of the MyD88-dependent pathway. J. Immunol. 2008, 181:4354-4362.
13. Malley R., Henneke P., Morse S.C., Cieslewicz M.J., Lipsitch M., Thompson C.M., Kurt-Jones E., Paton J.C., Wessels M.R., Golenbock D.T. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:1966-1971.
14. Manukyan M., Triantafilou K., Triantafilou M., Mackie A., Nilsen N., Espevik T., Wiesmuller K.H., Ulmer A.J., Heine H. Binding of lipopeptide to CD14 induces physical proximity of CD14, TLR2 and TLR1. Eur. J. Immunol. 2005, 35:911-921.
15. Moore L.J., Pridmore A.C., Dower S.K., Read R.C. Penicillin enhances the Toll-like receptor 2-mediated proinflammatory activity of Streptococcus pneumoniae. J. Infect. Dis. 2003, 188:1040-1048.
16. Nakata T., Yasuda M., Fujita M., Kataoka H., Kiura K., Sano H., Shibata K. CD14 directly binds to triacylated lipopeptides and facilitates recognition of the lipopeptides by the receptor complex of Toll-like receptors 2 and 1 without binding to the complex. Cell Microbiol. 2006, 8:1899-1909.
17. Ozinsky A., Underhill D.M., Fontenot J.D., Hajjar A.M., Smith K.D., Wilson C.B., Schroeder L., Aderem A. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:13766-13771.
18. Palsson-McDermott E.M., O'Neill L.A. Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology 2004, 113:153-162.
19. Peetermans W.E., Moffie B.G., Thompson J. Bacterial endocarditis caused by Streptococcus suis type 2. J. Infect. Dis. 1989, 159:595-596.
20. Rodriguez M.S., Thompson J., Hay R.T., Dargemont C. Nuclear retention of IkappaBalpha protects it from signal-induced degradation and inhibits nuclear factor kappaB transcriptional activation. J. Biol. Chem. 1999, 274:9108-9115.
21. Segura M., Stankova J., Gottschalk M. Heat-killed Streptococcus suis capsular type 2 strains stimulate tumor necrosis factor alpha and interleukin-6 production by murine macrophages. Infect. Immun. 1999, 67:4646-4654.
22. Segura M., Vanier G., Al-Numani D., Lacouture S., Olivier M., Gottschalk M. Proinflammatory cytokine and chemokine modulation by Streptococcus suis in a whole-blood culture system. FEMS Immunol. Med. Microbiol. 2006, 47:92-106.
23. Silva L.M., Baums C.G., Rehm T., Wisselink H.J., Goethe R., Valentin-Weigand P. Virulence-associated gene profiling of Streptococcus suis isolates by PCR. Vet. Microbiol. 2006, 115:117-127.
24. Sriskandan S., Slater J.D. Invasive disease and toxic shock due to zoonotic Streptococcus suis: an emerging infection in the East?. PLoS Med. 2006, 3:e187.
25. Staats J.J., Feder I., Okwumabua O., Chengappa M.M. Streptococcus suis: past and present. Vet. Res. Commun. 1997, 21:381-407.
26. Sutcliffe I.C., Harrington D.J. Pattern searches for the identification of putative lipoprotein genes in Gram-positive bacterial genomes. Microbiology 2002, 148:2065-2077.
27. Takeuchi O., Kawai T., Muhlradt P.F., Morr M., Radolf J.D., Zychlinsky A., Takeda K., Akira S. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int. Immunol. 2001, 13:933-940.
28. Takeuchi O., Sato S., Horiuchi T., Hoshino K., Takeda K., Dong Z., Modlin R.L., Akira S. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J. Immunol. 2002, 169:10-14.
29. Tang J., Wang C., Feng Y., Yang W., Song H., Chen Z., Yu H., Pan X., Zhou X., Wang H., Wu B., Wang H., Zhao H., Lin Y., Yue J., Wu Z., He X., Gao F., Khan A.H., Wang J., Zhao G.P., Wang Y., Wang X., Chen Z., Gao G.F. Streptococcal toxic shock syndrome caused by Streptococcus suis serotype 2. PLoS Med. 2006, 3:e151.
30. Thakran S., Li H., Lavine C.L., Miller M.A., Bina J.E., Bina X.R., Re F. Identification of Francisella tularensis lipoproteins that stimulate the Toll-like receptor (TLR) 2/TLR1 heterodimer. J. Biol. Chem. 2008, 283:3751-3760.
31. Travassos L.H., Girardin S.E., Philpott D.J., Blanot D., Nahori M.A., Werts C., Boneca I.G. Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition. EMBO Rep. 2004, 5:1000-1006.
32. Vadeboncoeur N., Segura M., Al-Numani D., Vanier G., Gottschalk M. Pro-inflammatory cytokine and chemokine release by human brain microvascular endothelial cells stimulated by Streptococcus suis serotype 2. FEMS Immunol. Med. Microbiol. 2003, 35:49-58.
33. Vecht U., Wisselink H.J., van Dijk J.E., Smith H.E. Virulence of Streptococcus suis type 2 strains in newborn germfree pigs depends on phenotype. Infect. Immun. 1992, 60:550-556.
34. von Heijne G. The structure of signal peptides from bacterial lipoproteins. Protein Eng. 1989, 2:531-534.
35. Wisselink H.J., Smith H.E., Stockhofe-Zurwieden N., Peperkamp K., Vecht U. Distribution of capsular types and production of muramidase-released protein (MRP) and extracellular factor (EF) of Streptococcus suis strains isolated from diseased pigs in seven European countries. Vet. Microbiol. 2000, 74:237-248.
36. Yu H., Jing H., Chen Z., Zheng H., Zhu X., Wang H., Wang S., Liu L., Zu R., Luo L., Xiang N., Liu H., Liu X., Shu Y., Lee S.S., Chuang S.K., Wang Y., Xu J., Yang W. Human Streptococcus suis outbreak, Sichuan, China. Emerg. Infect. Dis. 2006, 12:914-920.